SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (553)12/19/2001 12:40:03 PM
From: tuck  Read Replies (1) of 1005
 
I was expecting NWBT to break its IPO price before BAXS did, but no soap. NWBT is exhibiting the small support that held up SGEN for a little while. I might actually look to buy a little BAXS. Maybe I'll do it with Trickle first, just to have a pure X-Ray play there.

Meanwhile, since you and I both agree NWBT doesn't have much, BLUE HP will initiate a short at the current bid of $5.13 for 1000 shares. I expect to weather any seasonal effects into lock-up expiration, i.e. to hold the short for about six months. BLUE HP, profitable now, will have its numbers screwed up again by the SI portfolio interface, but c'est larvae.

Giving myself a small pat on the back for bailing on INGN at about the right time.

Edit: and I might add to the NWBT short on unwarranted strength.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News